Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model. Issue 1 (December 2015)
- Record Type:
- Journal Article
- Title:
- Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model. Issue 1 (December 2015)
- Main Title:
- Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model
- Authors:
- Aubry, Camille
Michon, Christophe
Chain, Florian
Chvatchenko, Yolande
Goffin, Laurence
Zimmerli, Simone
Leguin, Sylvia
Langella, Philippe
Bermudez-Humaran, Luis
Chatel, Jean-Marc - Abstract:
- Abstract Background Thymic stromal lymphopoietin (TSLP) is a cytokine known to mature dendritics cells, lower pro-inflammatory IL-12 secretion, induce differentiation of anti-inflammatory FoxP3+ regulatory T cells (Treg). Moreover, Crohn's disease patients have shown a reduction of intestinal TSLP expression. To understand the role of TSLP in inflammation, we constructedLactococcus lactis strain producing TSLP (LL-TSLP) and investigated the effect of its administration on dextran sulfate sodium (DSS)-induced colitis model in mice. Results LL-TSLP secrete an active molecule which lowers secretion of IL-12 by dendritic cells. Treatment with LL-TSLP, increases the amount of TGF-β secreted by T cells in Mesenteric Lymph Node in healthy mice. In acute DSS-induced colitis, LL-TSLP delayed the Disease Activity Index and lowered histological score and colonic INF-γ production. In a DSS-recovery model, LL-TSLP induced a better protective effect if the strain was administered at the beginning of the colitis. At Day 4 of colitis we observed an induction of Treg by LL-TSLP. Conclusions TSLP showed an anti-inflammatory protective role in DSS-induced colitis. We have demonstrated that a short and early administration of LL-TSLP is more efficient than a long lasting treatment.
- Is Part Of:
- Microbial cell factories. Volume 14:Issue 1(2015)
- Journal:
- Microbial cell factories
- Issue:
- Volume 14:Issue 1(2015)
- Issue Display:
- Volume 14, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 14
- Issue:
- 1
- Issue Sort Value:
- 2015-0014-0001-0000
- Page Start:
- 1
- Page End:
- 10
- Publication Date:
- 2015-12
- Subjects:
- TSLP -- Mucosal delivery -- Inflammatory bowel disease -- Lactococcus lactis
Microbial biotechnology -- Periodicals
Recombinant proteins -- Synthesis -- Periodicals
660.62 - Journal URLs:
- http://pubmedcentral.nih.gov/tocrender.fcgi?journal=100 ↗
http://www.biomedcentral.com/1475-2859 ↗
http://www.microbialcellfactories.com/ ↗
http://link.springer.com/ ↗ - DOI:
- 10.1186/s12934-015-0367-5 ↗
- Languages:
- English
- ISSNs:
- 1475-2859
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9959.xml